CODE,DESCRIPTION
8302-2,Body Height
72514-3,Pain severity - 0-10 verbal numeric rating [Score] - Reported
29463-7,Body Weight
77606-2,Weight-for-length Per age and sex
9843-4,Head Occipital-frontal circumference
8462-4,Diastolic Blood Pressure
8480-6,Systolic Blood Pressure
8867-4,Heart rate
9279-1,Respiratory rate
6690-2,Leukocytes [#/volume] in Blood by Automated count
789-8,Erythrocytes [#/volume] in Blood by Automated count
718-7,Hemoglobin [Mass/volume] in Blood
4544-3,Hematocrit [Volume Fraction] of Blood by Automated count
787-2,MCV [Entitic volume] by Automated count
785-6,MCH [Entitic mass] by Automated count
786-4,MCHC [Mass/volume] by Automated count
21000-5,Erythrocyte distribution width [Entitic volume] by Automated count
777-3,Platelets [#/volume] in Blood by Automated count
32207-3,Platelet distribution width [Entitic volume] in Blood by Automated count
32623-1,Platelet mean volume [Entitic volume] in Blood by Automated count
72166-2,Tobacco smoking status NHIS
6206-7,Peanut IgE Ab in Serum
6273-7,Walnut IgE Ab in Serum
6082-2,Codfish IgE Ab in Serum
6246-3,Shrimp IgE Ab in Serum
6276-0,Wheat IgE Ab in Serum
6106-9,Egg white IgE Ab in Serum
6248-9,Soybean IgE Ab in Serum
7258-7,Cow milk IgE Ab in Serum
6189-5,White oak IgE Ab in Serum
6085-5,Common Ragweed IgE Ab in Serum
6833-8,Cat dander IgE Ab in Serum
6095-4,American house dust mite IgE Ab in Serum
6075-6,Cladosporium herbarum IgE Ab in Serum
6844-5,Honey bee IgE Ab in Serum
6158-0,Latex IgE Ab in Serum
39156-5,Body Mass Index
59576-9,Body mass index (BMI) [Percentile] Per age and gender
QALY,QALY
DALY,DALY
QOLS,QOLS
70274-6,Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]
89204-2,Patient Health Questionnaire-9: Modified for Teens total score [Reported.PHQ.Teen]
76501-6,In the past year  have you been afraid of your partner or ex-partner?
93026-3,Do you feel physically and emotionally safe where you currently live?
93027-1,Are you a refugee?
93028-9,In the past year  have you spent more than 2 nights in a row in a jail  prison  detention center  or juvenile correctional facility?
93038-8,Stress is when someone feels tense  nervous  anxious or can't sleep at night because their mind is troubled. How stressed are you?
93029-7,How often do you see or talk to people that you care about and feel close to (For example: talking to friends on the phone  visiting friends or family  going to church or club meetings)?
93030-5,Has lack of transportation kept you from medical appointments  meetings  work  or from getting things needed for daily living?
93031-3,In the past year  have you or any family members you live with been unable to get any of the following when it was really needed?
63586-2,During the past year  what was the total combined income for you and the family members you live with? This information will help us determine if you are eligible for any benefits.
76437-3,What is your main insurance?
67875-5,What is your current work situation?
82589-3,What is the highest level of school that you have finished?
56799-0,What address do you live at?
93033-9,Are you worried about losing your housing?
71802-3,What is your housing situation today?
63512-8,How many family members  including yourself  do you currently live with?
54899-0,What language are you most comfortable speaking?
93034-7,Have you been discharged from the armed forces of the United States?
93035-4,At any point in the past 2 years  has season or migrant farm work been your or your family's main source of income?
32624-9,Which race(s) are you?
56051-6,Are you Hispanic or Latino?
55758-7,Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]
8310-5,Body temperature
76504-0,Total score [HARK]
75626-2,Total score [AUDIT-C]
82667-7,Total score [DAST-10]
2708-6,Oxygen saturation in Arterial blood
92142-9,Influenza virus A RNA [Presence] in Respiratory specimen by NAA with probe detection
92141-1,Influenza virus B RNA [Presence] in Respiratory specimen by NAA with probe detection
92131-2,Respiratory syncytial virus RNA [Presence] in Respiratory specimen by NAA with probe detection
92140-3,Parainfluenza virus 1 RNA [Presence] in Respiratory specimen by NAA with probe detection
92139-5,Parainfluenza virus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection
92138-7,Parainfluenza virus 3 RNA [Presence] in Respiratory specimen by NAA with probe detection
92130-4,Rhinovirus RNA [Presence] in Respiratory specimen by NAA with probe detection
92134-6,Human metapneumovirus RNA [Presence] in Respiratory specimen by NAA with probe detection
94040-3,Adenovirus A+B+C+D+E DNA [Presence] in Respiratory specimen by NAA with probe detection
94531-1,SARS-CoV-2 RNA Pnl Resp NAA+probe
2093-3,Total Cholesterol
2571-8,Triglycerides
18262-6,Low Density Lipoprotein Cholesterol
2085-9,High Density Lipoprotein Cholesterol
4548-4,Hemoglobin A1c/Hemoglobin.total in Blood
2339-0,Glucose
6299-2,Urea Nitrogen
38483-4,Creatinine
49765-1,Calcium
2947-0,Sodium
6298-4,Potassium
2069-3,Chloride
20565-8,Carbon Dioxide
14959-1,Microalbumin Creatinine Ratio
33914-3,Estimated Glomerular Filtration Rate
91146-1,What number best describes how  during the past week  pain has interfered with your general activity?
91145-3,What number best describes how  during the past week  pain has interfered with your enjoyment of life?
75893-8,What number best describes your pain on average in the past week?
65750-2,Drugs of abuse 5 panel - Urine by Screen method
38208-5,Pain severity - Reported
44261-6,Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]
20570-8,Hematocrit [Volume Fraction] of Blood
6690-2,WBC Auto (Bld) [#/Vol]
789-8,RBC Auto (Bld) [#/Vol]
21000-5,RDW - Erythrocyte distribution width Auto (RBC) [Entitic vol]
33914-3,Glomerular filtration rate/1.73 sq M.predicted
2885-2,Protein [Mass/volume] in Serum or Plasma
1751-7,Albumin [Mass/volume] in Serum or Plasma
10834-0,Globulin [Mass/volume] in Serum by calculation
1975-2,Bilirubin.total [Mass/volume] in Serum or Plasma
6768-6,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1742-6,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
69453-9,Cause of Death [US Standard Certificate of Death]
33756-8,Polyp size greatest dimension by CAP cancer protocols
57905-2,Hemoglobin.gastrointestinal [Presence] in Stool by Immunologic method
80382-5,Influenza virus A Ag [Presence] in Nasopharynx by Rapid immunoassay
80383-3,Influenza virus B Ag [Presence] in Nasopharynx by Rapid immunoassay
59460-6,Fall risk total [Morse Fall Scale]
59461-4,Fall risk level [Morse Fall Scale]
788-0,Erythrocyte distribution width [Ratio] by Automated count
770-8,Neutrophils/100 leukocytes in Blood by Automated count
736-9,Lymphocytes/100 leukocytes in Blood by Automated count
5905-5,Monocytes/100 leukocytes in Blood by Automated count
713-8,Eosinophils/100 leukocytes in Blood by Automated count
706-2,Basophils/100 leukocytes in Blood by Automated count
751-8,Neutrophils [#/volume] in Blood by Automated count
731-0,Lymphocytes [#/volume] in Blood by Automated count
742-7,Monocytes [#/volume] in Blood by Automated count
711-2,Eosinophils [#/volume] in Blood by Automated count
704-7,Basophils [#/volume] in Blood by Automated count
2345-7,Glucose [Mass/volume] in Serum or Plasma
3094-0,Urea nitrogen [Mass/volume] in Serum or Plasma
2160-0,Creatinine [Mass/volume] in Serum or Plasma
17861-6,Calcium [Mass/volume] in Serum or Plasma
2951-2,Sodium [Moles/volume] in Serum or Plasma
2823-3,Potassium [Moles/volume] in Serum or Plasma
2075-0,Chloride [Moles/volume] in Serum or Plasma
2028-9,Carbon dioxide  total [Moles/volume] in Serum or Plasma
48065-7,Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2276-4,Ferritin [Mass/volume] in Serum or Plasma
89579-7,Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method
14804-9,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2157-6,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1988-5,C reactive protein [Mass/volume] in Serum or Plasma
5902-2,Prothrombin time (PT)
6301-6,INR in Platelet poor plasma by Coagulation assay
33959-8,Procalcitonin [Mass/volume] in Serum or Plasma
26464-8,White Blood Cell (Elevated)
26453-1,Red Blood Cell
718-7,Hemoglobin
20570-8,Hematocrit
30428-7,MCV
30385-9,RBC Distribution Width
26515-7,Platelet Count
42719-5,Total Bilirubin (Elevated)
1742-6,ALT (Elevated)
1920-8,AST (Elevated)
2345-7,Glucose
3094-0,Urea Nitrogen
2160-0,Creatinine
17861-6,Calcium
2951-2,Sodium
2823-3,Potassium
2075-0,Chloride
2028-9,Carbon Dioxide
33037-3,Anion Gap
2885-2,Protein
1751-7,Albumin
10834-0,Globulin
6768-6,Alkaline Phosphatase
80271-0,Physical findings of Abdomen by Palpation
38265-5,DXA [T-score] Bone density
44667-4,Site of distant metastasis in Breast tumor
21907-1,Distant metastases.clinical [Class] Cancer
33728-7,Size.maximum dimension in Tumor
21905-5,Primary tumor.clinical [Class] Cancer
85343-2,Lymph nodes with macrometastases [#] in Cancer specimen by Light microscopy
21906-3,Regional lymph nodes.clinical [Class] Cancer
85319-2,HER2 [Presence] in Breast cancer specimen by Immune stain
85318-4,HER2 [Presence] in Breast cancer specimen by FISH
85337-4,Estrogen receptor Ag [Presence] in Breast cancer specimen by Immune stain
85339-0,Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain
417181009,Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain
21924-6,Tumor marker Cancer
21908-9,Stage group.clinical Cancer
88040-1,Response to cancer treatment
59557-9,Treatment status Cancer
5767-9,Appearance of Urine
5767-9,Odor of Urine
32167-9,Clarity of Urine
5778-6,Color of Urine
5792-7,Glucose [Mass/volume] in Urine by Test strip
25428-4,Glucose [Presence] in Urine by Test strip
20505-4,Bilirubin.total [Mass/volume] in Urine by Test strip
5770-3,Bilirubin.total [Presence] in Urine by Test strip
5797-6,Ketones [Mass/volume] in Urine by Test strip
2514-8,Ketones [Presence] in Urine by Test strip
5811-5,Specific gravity of Urine by Test strip
5803-2,pH of Urine by Test strip
5804-0,Protein [Mass/volume] in Urine by Test strip
20454-5,Protein [Presence] in Urine by Test strip
5802-4,Nitrite [Presence] in Urine by Test strip
5794-3,Hemoglobin [Presence] in Urine by Test strip
5799-2,Leukocyte esterase [Presence] in Urine by Test strip
88262-1,Gram positive blood culture panel by Probe in Positive blood culture
44963-7,Capillary refill [Time] of Nail bed
2713-6,Oxygen Saturation
59032-3,Lactate [Mass/volume] in Blood
8478-0,Mean blood pressure
85352-3,Lymph nodes with isolated tumor cells [#] in Cancer specimen by Light microscopy
10480-2,Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain
75325-1,Symptom
33762-6,NT-proBNP
19123-9,Magnesium [Mass/volume] in Serum or Plasma
2498-4,Iron [Mass/volume] in Serum or Plasma
2500-7,Iron binding capacity [Mass/volume] in Serum or Plasma
2502-3,Iron saturation [Mass Fraction] in Serum or Plasma
88020-3,Functional capacity NYHA
88021-1,Objective assessment of cardiovascular disease NYHA
10230-1,Left ventricular Ejection fraction
76690-7,Sexual orientation
55277-8,HIV status
28245-9,Abuse Status [OMAHA]
71802-3,Housing status
63513-6,Are you covered by health insurance or some other kind of health care plan [PhenX]
46240-8,History of Hospitalizations+Outpatient visits
19926-5,FEV1/FVC
32465-7,Physical findings of Prostate
2857-1,Prostate specific Ag [Mass/volume] in Serum or Plasma
46288-7,US Guidance for biopsy of Prostate
2744-1,pH of Arterial blood
2019-8,Carbon dioxide [Partial pressure] in Arterial blood
2703-7,Oxygen [Partial pressure] in Arterial blood
1960-4,Bicarbonate [Moles/volume] in Arterial blood
19994-3,Oxygen/Inspired gas setting [Volume Fraction] Ventilator
66519-0,Percentage area affected by eczema Head and Neck
66529-9,Percentage area affected by eczema Trunk
66524-0,Percentage area affected by eczema Upper extremitiy - bilateral
66534-9,Percentage area affected by eczema Lower extremitiy - bilateral
72106-8,Total score [MMSE]
99999-11,Withdrawal * as manifested by either of the following: a) Characteristic opioid withdrawal syndrome b) Same (or a closely related) substance is taken to relieve or avoid withdrawal symptoms
99999-10,Tolerance as defined by either of the following: a) Need for markedly increased amounts of opioids to achieve intoxication or desired effect b) Markedly diminished effect with continued use of the same amount of opioid
99999-9,Continued use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by opioids.
99999-8,Recurrent opioid use in situations in which it is physically hazardous
99999-7,Important social  occupational  or recreational activities are given up or reduced because of opioid use
99999-6,Continued opioid use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of opioids
99999-5,Recurrent opioid use resulting in a failure to fulfill major role obligations at work  school  or home
99999-4,Craving or a strong desire to use opioids
99999-3,A great deal of time is spent in activities necessary to obtain the opioid  use the opioid  or recover from its effects
99999-2,There is a persistent desire or unsuccessful efforts to cut down or control opioid use
99999-1,Opioids are often taken in larger amounts or over a longer period than was intended
74006-8,Weight difference [Mass difference] --pre dialysis - post dialysis
85344-0,Lymph nodes with micrometastases [#] in Cancer specimen by Light microscopy
3024-7,Thyroxine (T4) free [Mass/volume] in Serum or Plasma
3016-3,Thyrotropin [Units/volume] in Serum or Plasma
